US2016129165A1PendingUtilityA1

Medical devices having bioerodable layers for the release of therapeutic agents

Assignee: BOSTON SCIENT SCIMED INCPriority: Sep 14, 2007Filed: Jan 15, 2016Published: May 12, 2016
Est. expirySep 14, 2027(~1.2 yrs left)· nominal 20-yr term from priority
A61L 31/141A61L 31/10A61L 31/148A61L 2300/204A61L 2300/604A61L 31/16A61L 2420/08A61F 2002/30062A61L 27/502A61L 33/0052A61L 29/141
53
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

According to an aspect of the present invention, medical devices are provided which comprise: (a) a substrate and (b) bioerodable polymeric layer over the substrate that contains (i) one or more biodegradable polymers (ii) one or more therapeutic agents, and (iii) one or more plasticizers.

Claims

exact text as granted — not AI-modified
1 . A medical device comprising:
 a substrate; and   a bioerodable polymeric layer disposed over the substrate, the bioerodable polymeric layer including poly(lactic acid) or poly(lactic acid-co-glycolic acid) and a plasticizer selected from glycolic acid, an oligomer comprising glycolic acid, and combinations thereof.   
     
     
         2 . The medical device of  claim 1 , wherein the substrate comprises a stent. 
     
     
         3 . The medical device of  claim 1 , wherein the bioerodable polymeric layer further comprises a therapeutic agent. 
     
     
         4 . The medical device of  claim 3 , wherein the therapeutic agent is selected from antiproliferative agents, anti-thrombotic agents, anti-angiogenic agents, anti-restenotic agents, anti-inflammatory agents, anti-migratory agents, agents affecting extracellular matrix production and organization, antineoplastic agents, anti-mitotic agents, anesthetic agents, anti-coagulants, vascular cell growth promoters, vascular cell growth inhibitors, cholesterol-lowering agents, vasodilating agents, agents that interfere with endogenous vasoactive mechanisms, and combinations thereof. 
     
     
         5 . The medical device of  claim 1 , wherein the plasticizer comprises glycolic acid. 
     
     
         6 . The medical device of  claim 1 , wherein the plasticizer comprises an oligomer comprising glycolic acid. 
     
     
         7 . The medical device of  claim 1 , wherein the plasticizer comprises a combination of glycolic acid and an oligomer comprising glycolic acid. 
     
     
         8 . The medical device of  claim 1 , wherein the bioerodable polymeric layer is disposed over a portion of the substrate. 
     
     
         9 . The medical device of  claim 1 , wherein the bioerodable polymeric layer is disposed over all of the substrate. 
     
     
         10 . A stent comprising:
 a substrate; and   a bioerodable polymeric layer disposed over the substrate, the bioerodable polymeric layer including poly(lactic acid) or poly(lactic acid-co-glycolic acid) and a plasticizer selected from glycolic acid, an oligomer comprising glycolic acid, and combinations thereof.   
     
     
         11 . The stent of  claim 10 , wherein the stent has an abluminal surface and a luminal surface, and the biodegradable polymeric layer is disposed over the abluminal surface, but not the luminal surface. 
     
     
         12 . The stent of  claim 10 , wherein the substrate comprises a metallic substrate. 
     
     
         13 . The stent of  claim 10 , wherein the stent comprises a polymeric substrate. 
     
     
         14 . The stent of  claim 10 , wherein the biodegradable polymeric layer comprises poly(lactic acid-co-glycolic acid), and the poly(lactic acid-co-glycolic acid) comprises 30 to 100 wt % lactic acid and 0 to 70 wt % glycolic acid. 
     
     
         15 . The stent of  claim 10 , wherein the biodegradable polymeric layer has a number average molecular weight of 10,000 or more. 
     
     
         16 . The stent of  claim 10 , wherein the biodegradable polymeric layer has a number average molecular weight of 25,000 or more. 
     
     
         17 . A stent comprising:
 a substrate; and   a bioerodable polymeric layer disposed over the substrate, the bioerodable polymeric layer including 50 to 99 wt. % of poly(lactic acid) or poly(lactic acid-co-glycolic acid) and 1 to 50 wt. % of glycolic acid and/or an oligomer comprising glycolic acid.   
     
     
         18 . The stent of  claim 17 , wherein the substrate comprises a metallic substrate. 
     
     
         19 . The stent of  claim 17 , wherein the stent comprises a polymeric substrate. 
     
     
         20 . The stent of  claim 17 , wherein the stent has an abluminal surface and a luminal surface, and the biodegradable polymeric layer is disposed over the abluminal surface, but not the luminal surface.

Join the waitlist — get patent alerts

Track US2016129165A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.